Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Jeong Hwan Park, Jung Ho Kim

Clin Mol Hepatol. 2019;25(1):12-20. Published online October 5, 2018

DOI: https://doi.org/10.3350/cmh.2018.0067

View: 25825 Download: 1,127 Web of Science: 41 Crossref: 45

Meyoung Cho, M.D., Chang Soo Choi, M.D., Geom Seog Seo, M.D., Tae Hyeon Kim, M.D., Suck Chei Choi, M.D., Ki Jung Yun, M.D. Haak Cheoul Kim, M.D.

Clin Mol Hepatol. 2007;13(2):234-238. Published online January 1, 1970

View: 2841 Download: 22

Ji Hoon Kim , Joong Won Park , Joon Il Choi , Hyun Beom Kim , Dong Wook Koh , Woo Jin Lee , Chang Min Kim

Clin Mol Hepatol. 2007;13(1):91-95. Published online January 1, 1970

View: 2945 Download: 19

Min An, M.D., Jeong A Shin, M.D., Sang-Min Lee, M.D., Tak Yoon, M.D. Weon Seo Park, M.D. Joon Il Choi, M.D., and Chang-Min Kim, M.D.

Clin Mol Hepatol. 2006;12(4):562-567. Published online January 1, 1970

View: 2869 Download: 31

1 |

Viewed By 5240	MAFLD: How is it different from NAFLD?
Viewed By 4997	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4905	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4672	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4650	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 162	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 136	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 120	MAFLD: How is it different from NAFLD?
Cited By 98	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search